Douglas Cole

Equibles does not estimate personal net worth.

About Douglas Cole

Douglas Cole was last confirmed as Board Member at Sana Biotechnology, Inc. (SANA) in a filing dated April 26, 2022. Douglas Cole was last confirmed as Board Member at Denali Therapeutics Inc. (DNLI) in a filing dated April 18, 2023. Nauticus Robotics, Inc. reported in an 8-K filed September 15, 2022 that Douglas Cole resigned as director, effective September 9, 2022.

“Each of CLAQ's directors, Brendan Riley, Britt E. Ide, Jonas Grossman, Douglas Cole, Jon Najarian and Bill Richardson, prior to the Closing resigned from their respective position as a director of CLAQ, in each case effective as of the effective time on the Closing Date.”

Nauticus Robotics, Inc. Form 8-K, filed September 15, 2022 · Read the filing

Affiliation history

Denali Therapeutics Inc. (DNLI)
Board Member

Proxy statement

2015-01-01–2023-04-18

Last confirmed by a filing; no departure on record
Sana Biotechnology, Inc. (SANA)
Board Member

Proxy statement

Start not stated–2022-04-26

Last confirmed by a filing; no departure on record

Company network

Denali Therapeutics Inc.

DNLI

Biotechnology · Healthcare

Board Member

Since 2015-01-01, last confirmed 2023-04-18

Sana Biotechnology, Inc.

SANA

Biotechnology · Healthcare

Board Member

Recent activity

Executive change Resigned: director Nauticus Robotics, Inc. (KITT)
2022-09-09